Melatonin attenuates postmyocardial infarction injury via increasing Tom70 expression

Journal of Pineal Research

Volumn 62, Issue 1, 2017, Pages

  Pei, Hai Feng ^a   Hou, Juan Ni ^a   Wei, Fei Peng ^b   Xue, Qiang ^c   Zhang, Fan ^a   Peng, Cheng Fei ^d   Yang, Yi ^a   Tian, Yue ^a   Feng, Juan ^a   Du, Jin ^a   He, Lei ^a   Li, Xiu Chuan ^a   Gao, Er He ^e   Li, De ^a   Yang, Yong Jian ^a  

^a CHENGDU MILITARY GENERAL HOSPITAL   (China)

^b FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^c FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^d GENERAL HOSPITAL OF NORTHERN THEATER COMMAND   (China)

^e TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

melatonin; mitochondria; myocardial infarction; reactive oxygen species; Tom70

Indexed keywords

ACETYLCYSTEINE; ADENOSINE TRIPHOSPHATE; ANTIOXIDANT; CARRIER PROTEIN; CASPASE 3; DNA NUCLEOTIDYLEXOTRANSFERASE; HYDROETHIDINE; LENTIVIRUS VECTOR; LUCIGENIN; LUZINDOLE; MELATONIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR 1ALPHA; REACTIVE OXYGEN METABOLITE; SMALL INTERFERING RNA; TOM70 PROTEIN; UNCLASSIFIED DRUG; TOM70 PROTEIN, MOUSE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CARDIAC MUSCLE CELL; CELL DAMAGE; CELLS; CONTROLLED STUDY; DOWN REGULATION; ECHOCARDIOGRAPHY; HEART FUNCTION; HEART INFARCTION; HEART LEFT VENTRICLE; HEART MUSCLE FIBROSIS; LEFT ANTERIOR DESCENDING CORONARY ARTERY; LUMINESCENCE; MALE; MITOCHONDRION; MOUSE; MYOCARDIAL ISCHEMIA REPERFUSION INJURY; NONHUMAN; OXIDATIVE STRESS; PROTEIN EXPRESSION; TRANSMISSION ELECTRON MICROSCOPY; TUNEL ASSAY; UPREGULATION; ANIMAL; C57BL MOUSE; DISEASE MODEL; DRUG EFFECTS; GENE SILENCING; METABOLISM; PATHOLOGY; PHYSIOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION;

ANIMALS; APOPTOSIS; DISEASE MODELS, ANIMAL; GENE KNOCKDOWN TECHNIQUES; MALE; MELATONIN; MICE; MICE, INBRED C57BL; MITOCHONDRIAL MEMBRANE TRANSPORT PROTEINS; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION INJURY; MYOCYTES, CARDIAC; REACTIVE OXYGEN SPECIES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION;

EID: 84995920282     PISSN: 07423098     EISSN: 1600079X     Source Type: Journal    
DOI: 10.1111/jpi.12371     Document Type: Article

References (56)

1. Makarewich CA, Zhang H, Davis J, et al. Transient receptor potential channels contribute to pathological structural and functional remodeling after myocardial infarction. Circ Res. 2014;115:567–580.
2. Chandrasekhar J, Mehran R. The ideal anticoagulation strategy in st-elevation myocardial infarction. Prog Cardiovasc Dis. 2015;58:247–259.
3. Spiliopoulos S, Koerfer R, Tenderich G. Acute myocardial infarction complicated by cardiogenic shock: results of primary percutaneous coronary interventions are insufficient. Eur J Cardiothorac Surg. 2016;49:1298.
4. Ong SB, Hall AR, Hausenloy DJ. Mitochondrial dynamics in cardiovascular health and disease. Antioxid Redox Signal. 2013;19:400–414.
5. Kurokawa S, Niwano S, Niwano H, et al. Cardiomyocyte-derived mitochondrial superoxide causes myocardial electrical remodeling by downregulating potassium channels and related molecules. Circ J. 2014;78:1950–1959.
6. Baker MJ, Frazier AE, Gulbis JM, et al. Mitochondrial protein-import machinery: correlating structure with function. Trends Cell Biol. 2007;17:456–464.
7. Schmidt O, Harbauer AB, Rao S, et al. Regulation of mitochondrial protein import by cytosolic kinases. Cell. 2011;144:227–239.
8. Bermejo-Nogales A, Nederlof M, Benedito-Palos L, et al. Metabolic and transcriptional responses of gilthead sea bream (sparus aurata l.) to environmental stress: new insights in fish mitochondrial phenotyping. Gen Comp Endocrinol. 2014;205:305–315.
9. Yamamoto H, Fukui K, Takahashi H, et al. Roles of tom70 in import of presequence-containing mitochondrial proteins. J Biol Chem. 2009;284:31635–31646.
10. Kato H, Lu Q, Rapaport D, et al. Tom70 is essential for pink1 import into mitochondria. PLoS ONE. 2013;8:e58435.
11. Siddall HK, Yellon DM, Ong SB, et al. Loss of pink1 increases the heart's vulnerability to ischemia-reperfusion injury. PLoS ONE. 2013;8:e62400.
12. Li J, Qi M, Li C, et al. Tom70 serves as a molecular switch to determine pathological cardiac hypertrophy. Cell Res. 2014;24:977–993.
13. Markevich NI, Hoek JB. Computational modeling analysis of mitochondrial superoxide production under varying substrate conditions and upon inhibition of different segments of the electron transport chain. Biochim Biophys Acta. 2015;1847:656–679.
14. Pei H, Yang Y, Zhao H, et al. The role of mitochondrial functional proteins in ros production in ischemic heart diseases. Oxid Med Cell Longev. 2016;2016:5470457.
15. Kyrychenko V, Polakova E, Janicek R, et al. Mitochondrial dysfunctions during progression of dystrophic cardiomyopathy. Cell Calcium. 2015;58:186–195.
16. Giordano FJ. Oxygen, oxidative stress, hypoxia, and heart failure. J Clin Invest. 2005;115:500–508.
17. Zhu P, Liu J, Shi J, et al. Melatonin protects adscs from ros and enhances their therapeutic potency in a rat model of myocardial infarction. J Cell Mol Med. 2015;19:2232–2243.
18. Vazan R, Ravingerova T. Protective effect of melatonin against myocardial injury induced by epinephrine. J Physiol Biochem. 2015;71:43–49.
19. Amin AH, El-Missiry MA, Othman AI. Melatonin ameliorates metabolic risk factors, modulates apoptotic proteins, and protects the rat heart against diabetes-induced apoptosis. Eur J Pharmacol. 2015;747:166–173.
20. Dominguez-Rodriguez A, Abreu-Gonzalez P, Arroyo-Ucar E, et al. Decreased level of melatonin in serum predicts left ventricular remodelling after acute myocardial infarction. J Pineal Res. 2012;53:319–323.
21. Reiter RJ, Tan DX, Manchester LC, et al. Medical implications of melatonin: receptor-mediated and receptor-independent actions. Adv Med Sci. 2007;52:11–28.
22. Teng YC, Tai YI, Huang HJ, et al. Melatonin ameliorates arsenite-induced neurotoxicity: involvement of autophagy and mitochondria. Mol Neurobiol. 2015;52:1015–1022.
23. Teodoro BG, Baraldi FG, Sampaio IH, et al. Melatonin prevents mitochondrial dysfunction and insulin resistance in rat skeletal muscle. J Pineal Res. 2014;57:155–167.
24. Chen Y, Qing W, Sun M, et al. Melatonin protects hepatocytes against bile acid-induced mitochondrial oxidative stress via the ampk-sirt3-sod2 pathway. Free Radic Res. 2015;49:1275–1284.
25. Li Q, Xie J, Li R, et al. Overexpression of microrna-99a attenuates heart remodelling and improves cardiac performance after myocardial infarction. J Cell Mol Med. 2014;18:919–928.
26. Salama M, Elgamal M, Abdelaziz A, et al. Toll-like receptor 4 blocker as potential therapy for acetaminophen-induced organ failure in mice. Exp Ther Med. 2015;10:241–246.
27. Pei H, Song X, Peng C, et al. Tnf-alpha inhibitor protects against myocardial ischemia/reperfusion injury via notch1-mediated suppression of oxidative/nitrative stress. Free Radic Biol Med. 2015;82:114–121.
28. Yu L, Sun Y, Cheng L, et al. Melatonin receptor-mediated protection against myocardial ischemia/reperfusion injury: role of sirt1. J Pineal Res. 2014;57:228–238.
29. Pei H, Qu Y, Lu X, et al. Cardiac-derived adiponectin induced by long-term insulin treatment ameliorates myocardial ischemia/reperfusion injury in type 1 diabetic mice via ampk signaling. Basic Res Cardiol. 2013;108:322.
30. Liu S, Yin T, Wei X, et al. Downregulation of adiponectin induced by tumor necrosis factor alpha is involved in the aggravation of posttraumatic myocardial ischemia/reperfusion injury. Crit Care Med. 2011;39:1935–1943.
31. Pei H, Yu Q, Xue Q, et al. Notch1 cardioprotection in myocardial ischemia/reperfusion involves reduction of oxidative/nitrative stress. Basic Res Cardiol. 2013;108:373.
32. Yellon DM, Hausenloy DJ. Myocardial reperfusion injury. N Engl J Med. 2007;357:1121–1135.
33. Parameyong A, Charngkaew K, Govitrapong P, et al. Melatonin attenuates methamphetamine-induced disturbances in mitochondrial dynamics and degeneration in neuroblastoma sh-sy5y cells. J Pineal Res. 2013;55:313–323.
34. Hollander JM, Thapa D, Shepherd DL. Physiological and structural differences in spatially distinct subpopulations of cardiac mitochondria: influence of cardiac pathologies. Am J Physiol Heart Circ Physiol. 2014;307:H1–H14.
35. Neupert W, Herrmann JM. Translocation of proteins into mitochondria. Annu Rev Biochem. 2007;76:723–749.
36. Lithgow T, Glick BS, Schatz G. The protein import receptor of mitochondria. Trends Biochem Sci. 1995;20:98–101.
37. Young JC, Hoogenraad NJ, Hartl FU. Molecular chaperones hsp90 and hsp70 deliver preproteins to the mitochondrial import receptor tom70. Cell. 2003;112:41–50.
38. Suzuki H, Maeda M, Mihara K. Characterization of rat tom70 as a receptor of the preprotein translocase of the mitochondrial outer membrane. J Cell Sci. 2002;115:1895–1905.
39. Indo HP, Yen HC, Nakanishi I, et al. A mitochondrial superoxide theory for oxidative stress diseases and aging. J Clin Biochem Nutr. 2015;56:1–7.
40. Tanaka K, Honda M, Takabatake T. Redox regulation of mapk pathways and cardiac hypertrophy in adult rat cardiac myocyte. J Am Coll Cardiol. 2001;37:676–685.
41. Hassan MQ, Akhtar MS, Akhtar M, et al. Edaravone protects rats against oxidative stress and apoptosis in experimentally induced myocardial infarction: biochemical and ultrastructural evidence. Redox Rep. 2015;20:275–281.
42. Rosca MG, Tandler B, Hoppel CL. Mitochondria in cardiac hypertrophy and heart failure. J Mol Cell Cardiol. 2013;55:31–41.
43. Writing Committee M, Yancy CW, Jessup M, et al. ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. Circulation. 2013;2013:e240–e327.
44. Lee YM, Chen HR, Hsiao G, et al. Protective effects of melatonin on myocardial ischemia/reperfusion injury in vivo. J Pineal Res. 2002;33:72–80.
45. Lu Q, Yi X, Cheng X, et al. Melatonin protects against myocardial hypertrophy induced by lipopolysaccharide. In Vitro Cell Dev Biol Anim. 2015;51:353–360.
46. Idikio HA. Postmyocardial infarct remodeling and heart failure: potential contributions from pro- and antiaging factors. Cardiol Res Pract. 2011;2011:836806.
47. Yeung HM, Hung MW, Lau CF, et al. Cardioprotective effects of melatonin against myocardial injuries induced by chronic intermittent hypoxia in rats. J Pineal Res. 2015;58:12–25.
48. Yu L, Liang H, Lu Z, et al. Membrane receptor-dependent notch1/hes1 activation by melatonin protects against myocardial ischemia-reperfusion injury: in vivo and in vitro studies. J Pineal Res. 2015;59:420–433.
49. Gurer-Orhan H, Karaaslan C, Ozcan S, et al. Novel indole-based melatonin analogues: evaluation of antioxidant activity and protective effect against amyloid beta-induced damage. Bioorg Med Chem. 2016;24:1658–1664.
50. Suwanjang W, Abramov AY, Charngkaew K, et al. Melatonin prevents cytosolic calcium overload, mitochondrial damage and cell death due to toxically high doses of dexamethasone-induced oxidative stress in human neuroblastoma sh-sy5y cells. Neurochem Int. 2016;97:34–41.
51. Kato H, Tanaka G, Masuda S, et al. Melatonin promotes adipogenesis and mitochondrial biogenesis in 3t3-l1 preadipocytes. J Pineal Res. 2015;59:267–275.
52. Liu LF, Qin Q, Qian ZH, et al. Protective effects of melatonin on ischemia-reperfusion induced myocardial damage and hemodynamic recovery in rats. Eur Rev Med Pharmacol Sci. 2014;18:3681–3686.
53. Paradies G, Petrosillo G, Paradies V, et al. Melatonin, cardiolipin and mitochondrial bioenergetics in health and disease. J Pineal Res. 2010;48:297–310.
54. Yang Y, Jiang S, Dong Y, et al. Melatonin prevents cell death and mitochondrial dysfunction via a sirt1-dependent mechanism during ischemic-stroke in mice. J Pineal Res. 2015;58:61–70.
55. Manchester LC, Coto-Montes A, Boga JA, et al. Melatonin: an ancient molecule that makes oxygen metabolically tolerable. J Pineal Res. 2015;59:403–419.
56. Mathes AM, Wolf B, Rensing H. Melatonin receptor antagonist luzindole is a powerful radical scavenger in vitro. J Pineal Res. 2008;45:337–338.